Every two years, the American Cancer Society publishes a new report on breast cancer trends. The latest report came out earlier this month.
What does the new report tell us? Are we really making a great deal of progress against breast cancer as some of the media stories are presenting it? Or is progress more incremental in nature?
And how might we respond in a way that could make a difference–during this month of October and during the rest of the year as well?
What’s the latest news in cancer research that stands out the most? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this summer.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
Topics covered this time include the first approval of a cancer drug based on a biomarker rather than the where in the body the cancer started, as well as a first approval for an innovative therapy in which a patient’s immune system cells are genetically engineered to attack cancer.
In this post, I’m taking up a summer blogging challenge posed by Nancy at Nancy’s Point to answer ten random questions about cancer that she has put together.
Nancy has shared her answers to the ten questions, and asked other bloggers and readers to join in and answer as many as they like. It sounds like a great opportunity for all of who read or write blogs to get to know each other a little better!
So, here are my answers to Nancy’s ten random questions about cancer. Continue reading
Like many of us, I’ve long felt that one of the best ways to help in the fight against cancer is by making a donation to a charity that conducts or funds cancer research.
Of course, there are many outstanding cancer charities that provide other critical services to the community including patient support and advocacy, and I contribute to several of them. In that vein, I’ve shared my ideas in an earlier post on contributing to breast cancer charities.
However, the focus of this blog is cancer research in particular, and this post is the fourth in a series in which we’re taking a look at high quality charities that support cancer research as their main focus. In this post, we’ll review the Cancer Research Institute, including its mission and approach, history, notable financial facts and results reporting. Continue reading
Back in August 2015, I wrote about an article in the journal Nature on some interesting new discoveries about the role of the hormone progesterone in hormone receptor-positive breast cancer.
The research suggested that adding progesterone to standard treatment with tamoxifen or an aromatase inhibitor could increase the effectiveness of treatment for this subtype of breast cancer, while possibly also lowering toxicity.
Cancer Research UK reports that these findings are now going to be investigated in three clinical trials that are set to begin. Continue reading
What’s the latest news in cancer research that we need to know about? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this spring.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
Topics covered this time include studies reported at the recent annual meeting of the American Association for Cancer Research on the use of PARP inhibitors to treat different types of cancer, as well as a study on the benefits of immunotherapy for triple negative breast cancer.
What in the world is “step therapy”? Maybe a new type of fitness routine? Unfortunately, it’s nothing of the kind. And this benign sounding term can sometimes mean bad news for cancer patients and others who need newer, but often more costly, medications that have been prescribed by their doctors.
This February, I joined a group of advocates for meetings at our state legislature here in Virginia. One of the major issues on our agenda was the need for reform of the practice of step therapy, which has increased significantly across the country in recent years with the rising prices of prescription drugs. Continue reading
I’ve been looking forward to reading Siddhartha Mukherjee’s latest book, “The Gene: An Intimate History”, since it was published last year.
His Pulitzer prize-winning “The Emperor of All Maladies” is one of the most interesting and informative books about cancer that I’ve read. In addition, now that genome sequencing and other forms of genetic testing are becoming more accessible and more common, I hoped this new book would provide some insights about where we are in all of this and what we might realistically expect from more expansive genetic testing in the years to come. Continue reading
What’s the latest news in cancer research that we need to know about? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this winter.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further.
Topics covered this time include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer, and new imaging technology that could provide a noninvasive way to monitor ongoing treatment.
One of the things I enjoy about the holiday season is that it usually includes some down time to reflect a bit on the past year and opportunities the new year brings.
As we start this new year, I’m looking forward to (hopefully) a wonderful year ahead, but it’s hard not to also recognize that there are many uncertainties at play in the larger world today.
I’ve been thinking lately about some of the lessons I’ve learned going through difficult times in the past. One of those lessons was recognizing that even when our world seems to be veering off course, there are things we can control. And those are the small and large (mostly small) choices we make and actions we take every day that add up to the kind of year we have and the life we live.
